ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: TGFβ signalling is linked to poor TKI response in CML, with enrichment of the pathway observed at the single-cell level in poorly responding BCR-ABL− and BCR-ABL+ CML cells33.